Dr Edward Carden, MD | |
13160 Mindanao Way, Suite 300, Marina Del Rey, CA 90292-6358 | |
(310) 842-8668 | |
(310) 842-8669 |
Full Name | Dr Edward Carden |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 13160 Mindanao Way, Marina Del Rey, California |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1811942410 | NPI | - | NPPES |
00A267740 | Other | CA | BLUE SHIELD |
00A267740 | Medicaid | CA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208VP0000X | Pain Medicine - Pain Medicine | A26774 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Edward Carden, MD 13160 Mindanao Way, Suite 300, Marina Del Rey, CA 90292-6358 Ph: (310) 842-8668 | Dr Edward Carden, MD 13160 Mindanao Way, Suite 300, Marina Del Rey, CA 90292-6358 Ph: (310) 842-8668 |
News Archive
Researchers studying the evolutionary dynamics of bacteria and viruses in bubbling glass tubes have confirmed an evolutionary theory of central importance to ecologists studying more familiar flora and fauna in the wild.
Hospitals have spent millions of dollars on computerized physician order entry systems to reduce medical errors, but a simple change in the way verbal orders are entered in the system - so simple that it cost nothing to implement - has reduced errors to zero, according to a new Cincinnati Children's Hospital Medical Center study.
Today, Veeva Systems announced that it has acquired Merqurio's healthcare professional (HCP) and healthcare organisation (HCO) database for Italy. With the acquisition of this market-leading Italian HCP and stakeholder data, Veeva OpenData now expands to a third major European market and builds on Veeva's commitment to deliver a new approach to customer reference data that is open, easy, and global.
Pacira Pharmaceuticals, Inc. today announced the publication of data from a placebo-controlled, pivotal Phase 3 trial of EXPAREL (bupivacaine liposome injectable suspension), a non-opioid local analgesic that was recently approved by the U.S. Food and Drug Administration (FDA) for administration into the surgical site to produce postsurgical analgesia.
› Verified 3 days ago